The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Leptomeningeal metastasis from systemic cancer: Review and update on management
Open accessAbstract
Leptomeningeal metastasis is an uncommon and typically late complication of cancer with a poor prognosis and limited treatment options. Diagnosis is often challenging, with nonspecific presenting symptoms ranging from headache and confusion to focal neurologic deficits, such as cranial nerve palsies. Standard diagnostic evaluation involves a neurologic examination, magnetic resonance imaging of the brain and spine with gadolinium, and cytologic evaluation of the cerebral spinal fluid. Therapy entails a multimodal approach focused on palliation with surgery, radiation, and/or chemotherapy, which may be administered systemically or directly into the cerebral spinal fluid. Limited trial data exist to guide treatment, and current regimens are based primarily on expert opinion. Although newer targeted and immunotherapeutic agents are under investigation and have shown promise, an improved understanding of the biology of leptomeningeal metastasis and treatment resistance as well as additional randomized controlled studies are needed to guide the optimal treatment of this devastating disease. Cancer 2018;124:21‐35. © 2017 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Robert, C., Karaszewska, B., Schachter, J., Rutkowski, P., Mackiewicz, A., Stroiakovski, D., Lichinitser, M., Dummer, R., Grange, F., Mortier, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412690 · Cited by 2,701
Barnholtz-Sloan, J. S., Sloan, A. E., Davis, F. G., Vigneau, F. D., Lai, P., & Sawaya, R. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.149 · Cited by 1,843
Long, G. V., Stroyakovskiy, D., Gogas, H., Levchenko, E., de Braud, F., Larkin, J., Garbe, C., Jouary, T., Hauschild, A., Grob, J.-J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60898-4 · Cited by 1,399
Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients
Wasserstrom, W. R., Glass, J. P., & Posner, J. B. (1982) · Cancer · doi:10.1002/1097-0142(19820215)49:4<759::aid-cncr2820490427>3.0.co;2-7 · Cited by 1,124
Ascierto, P. A., McArthur, G. A., Dréno, B., Atkinson, V., Liszkay, G., Di Giacomo, A. M., Mandalà, M., Demidov, L., Stroyakovskiy, D., Thomas, L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30122-x · Cited by 1,022
Bachelot, T., Romieu, G., Campone, M., Diéras, V., Cropet, C., Dalenc, F., Jimenez, M., Le Rhun, E., Pierga, J.-Y., Gonçalves, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70432-1 · Cited by 737
Bonvalot, S., Rivoire, M., Castaing, M., Stoeckle, E., Le Cesne, A., Blay, J. Y., & Laplanche, A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0802 · Cited by 644
Infiltration of the Leptomeninges by Systemic Cancer
Olson, M. E. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490320010002 · Cited by 572
Glantz, M., Jaeckle, K. A., Chamberlain, M. C., Phuphanich, S., Recht, L. D., Swinnen, L. J., Maria, B., LaFollette, S., Schumann, G. B., Cole, B. F., et al. (1999) · PubMed · Cited by 529
Grossman, S. A., & Krabak, M. J. (1999) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0119 · Cited by 529
Aparicio, A., & Chamberlain, M. C. (2002) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-002-0081-7 · Cited by 487
Cerebrospinal fluid cytology in patients with cancer: Minimizing false-negative results
Glantz, M. J., Cole, B. F., Glantz, L. K., Cobb, J., Mills, P., Lekos, A., Walters, B. C., & Recht, L. D. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980215)82:4<733::aid-cncr17>3.0.co;2-z · Cited by 456
Leptomeningeal metastases in the MRI era
Clarke, J. L., Perez, H. R., Jacks, L. M., Panageas, K. S., & DeAngelis, L. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dc1a69 · Cited by 432
Pentsova, E. I., Shah, R. H., Tang, J., Boire, A., You, D., Briggs, S., Omuro, A., Lin, X., Fleisher, M., Grommes, C., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.6487 · Cited by 417
Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis
Freilich, R. J., Krol, G., & Deangelis, L. M. (1995) · Annals of Neurology · doi:10.1002/ana.410380111 · Cited by 412
CNS complications of radiotherapy and chemotherapy
Soussain, C., Ricard, D., Fike, J. R., Mazeron, J.-J., Psimaras, D., & Delattre, J.-Y. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61299-x · Cited by 410
Glantz, M. J., LaFollette, S., Jaeckle, K. A., Shapiro, W., Swinnen, L., Rozental, J. R., Phuphanich, S., Rogers, L. R., Gutheil, J. C., Batchelor, T., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3110 · Cited by 402
Complement Component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis.
Boire, A., Zou, Y., Shieh, J., Macalinao, D. G., Pentsova, E., & Massagué, J. (2017) · Cell · doi:10.1016/j.cell.2017.02.025 · Cited by 366 · cited 1×
“Recent studies have started to shed light on the pathogenesis, however, with 1 study demonstrating that cancer cells within the cerebrospinal fluid (CSF) upregulate the production of complement component 3.(3) This, in turn, leads to disruption of the BBB and entry of plasma growth factors into the CSF, promoting canc…”
BackgroundGrossman, S. A., Finkelstein, D. M., Ruckdeschel, J. C., Trump, D. L., Moynihan, T., & Ettinger, D. S. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.561 · Cited by 364
Hitchins, R. N., Bell, D. R., Woods, R. L., & Levi, J. A. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.10.1655 · Cited by 352
Grommes, C., Oxnard, G. R., Kris, M. G., Miller, V. A., Pao, W., Holodny, A. I., Clarke, J. L., & Lassman, A. B. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor121 · Cited by 349
Neurotoxicity and Elevated Cerebrospinal-Fluid Methotrexate Concentration in Meningeal Leukemia
Bleyer, W. A., Drake, J. C., & Chabner, B. A. (1973) · New England Journal of Medicine · doi:10.1056/nejm197310112891503 · Cited by 337
Glantz, M. J., Cole, B. F., Recht, L., Akerley, W., Mills, P., Saris, S., Hochberg, F., Calabresi, P., & Egorin, M. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1561 · Cited by 322
Epidemiology of Metastatic Brain Tumors
Fox, B. D., Cheung, V. J., Patel, A. J., Suki, D., & Rao, G. (2011) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2010.08.007 · Cited by 317
Leptomeningeal metastases: a RANO proposal for response criteria
Chamberlain, M., Junck, L., Brandsma, D., Soffietti, R., Rudà, R., Raizer, J., Boogerd, W., Taillibert, S., Groves, M. D., Rhun, E. L., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now183 · Cited by 317
Brain Tumor Mutations Detected in Cerebral Spinal Fluid
Pan, W., Gu, W., Nagpal, S., Gephart, M. H., & Quake, S. R. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.235457 · Cited by 297
Boogerd, W., van den Bent, M. J., Koehler, P. J., Heimans, J. J., van der Sande, J. J., Aaronson, N. K., Hart, A. A. M., Benraadt, J., & Vecht, C. J. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.08.012 · Cited by 286
Morris, P. G., Reiner, A. S., Szenberg, O. R., Clarke, J. L., Panageas, K. S., Perez, H. R., Kris, M. G., Chan, T. A., DeAngelis, L. M., & Omuro, A. M. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182398e4f · Cited by 280
Jackman, D. M., Holmes, A. J., Lindeman, N., Wen, P. Y., Kesari, S., Borras, A. M., Bailey, C., de Jong, F., Jänne, P. A., & Johnson, B. E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.6126 · Cited by 260
Hoffknecht, P., Tufman, A., Wehler, T., Pelzer, T., Wiewrodt, R., Schütz, M., Serke, M., Stöhlmacher-Williams, J., Märten, A., Maria Huber, R., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000380 · Cited by 252
Straathof, C. S. M., de Bruin, H. G., Dippel, D. W. J., & Vecht, C. J. (1999) · Journal of Neurology · doi:10.1007/s004150050459 · Cited by 251
Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours
Beauchesne, P. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70034-6 · Cited by 223
Clarke, J. L., Pao, W., Wu, N., Miller, V. A., & Lassman, A. B. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0128-6 · Cited by 214
Gow, C.-H., Chang, Y.-L., Hsu, Y.-C., Tsai, M.-F., Wu, C.-T., Yu, C.-J., Yang, C.-H., Lee, Y.-C., Yang, P.-C., & Shih, J.-Y. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn679 · Cited by 213
Kesari, S., & Batchelor, T. T. (2003) · Neurologic Clinics · doi:10.1016/s0733-8619(02)00032-4 · Cited by 211
Park, J. H., Kim, Y. J., Lee, J.-O., Lee, K.-W., Kim, J. H., Bang, S.-M., Chung, J.-H., Kim, J. S., & Lee, J. S. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2011.11.022 · Cited by 174
Leptomeningeal metastasis: survival and prognostic factors in 155 patients
Herrlinger, U., Förschler, H., Küker, W., Meyermann, R., Bamberg, M., Dichgans, J., & Weller, M. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.05.008 · Cited by 173
Gainor, J. F., Sherman, C. A., Willoughby, K., Logan, J., Kennedy, E., Brastianos, P. K., Chi, A. S., & Shaw, A. T. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000455 · Cited by 168
Self-citationChamberlain, M., Soffietti, R., Raizer, J., Ruda, R., Brandsma, D., Boogerd, W., Taillibert, S., Groves, M. D., Le Rhun, E., Junck, L., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou089 · Cited by 163
Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis
Grossman, S. A., Trump, D. L., Chen, D. C. P., et al. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90404-1 · Cited by 161
Leptomeningeal metastases from solid tumors
Bokstein, F., Lossos, A., & Siegal, T. (1998) · Cancer · Cited by 155
Bokstein, F., Lossos, A., & Siegal, T. (1998) · PubMed · Cited by 153
Leptomeningeal metastasis: Clinical experience of 519 cases
Hyun, J., Jeong, I. H., Joung, A., Cho, H. J., Kim, S., & Kim, H. J. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.12.021 · Cited by 153
Waki, F., Ando, M., Takashima, A., Yonemori, K., Nokihara, H., Miyake, M., Tateishi, U., Tsuta, K., Shimada, Y., Fujiwara, Y., et al. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9758-3 · Cited by 145 · cited 2×
“0 years in solid tumors and averages 11 months in hematologic malignancies.(14,16,17) CLINICAL PRESENTATION AND DIFFERENTIAL DIAGNOSIS Signs and symptoms of LM depend on the location of involvement.”
BackgroundBreast cancer leptomeningeal metastasis—the role of multimodality treatment
Rudnicka, H., Niwińska, A., & Murawska, M. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9340-4 · Cited by 141
Carcinoma Meningitis Secondary to Non–Small Cell Lung Cancer: Combined Modality Therapy
Chamberlain, M. C., & Kormanik, P. A. (1998) · Archives of Neurology · doi:10.1001/archneur.55.4.506 · Cited by 141
Siegal, T., Lossos, A., & Pfeffer, M. R. (1994) · Neurology · doi:10.1212/wnl.44.8.1463 · Cited by 138
Umemura, S., Tsubouchi, K., Yoshioka, H., Hotta, K., Takigawa, N., Fujiwara, K., Horita, N., Segawa, Y., Hamada, N., Takata, I., et al. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.03.002 · Cited by 135
Zagouri, F., Sergentanis, T. Ν., Bartsch, R., Berghoff, A. S., Chrysikos, D., de Azambuja, E., Dimopoulos, M. A., & Preusser, M. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2525-y · Cited by 133
Yi, H. G., Kim, H. J., Kim, Y. J., Han, S., Oh, D., Lee, S., Kim, D., Im, S., Kim, T., Kim, C. S., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.10.016 · Cited by 128
Imaging features of leptomeningeal metastases
Collie, D. A., Brush, J. P., Lammie, G. A., Grant, R. A., Kunkler, I. H., Leonard, R. C., Gregor, A., & Sellar, R. J. (1999) · Clinical Radiology · doi:10.1016/s0009-9260(99)91181-9 · Cited by 125
Systemic high-dose intravenous methotrexate for central nervous system metastases
Lassman, A. B., Abrey, L. E., Shah, G. G., Panageas, K. S., Begemann, M., Malkin, M. G., & Raizer, J. J. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9044-6 · Cited by 124
Oechsle, K., Lange-Brock, V., Kruell, A., Bokemeyer, C., & de Wit, M. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0831-x · Cited by 119
Elmeliegy, M. A., Carcaboso, A. M., Tagen, M., Bai, F., & Stewart, C. F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1934 · Cited by 118
Pan, Z., Yang, G., He, H., Zhao, G., Yuan, T., Li, Y., Shi, W., Gao, P., Dong, L., & Li, Y. (2016) · International Journal of Cancer · doi:10.1002/ijc.30214 · Cited by 116
Diffuse involvement of the leptomeninges by tumour--a clinical and pathological study of 63 cases
Boyle, R., Thomas, M., & Adams, J. H. (1980) · Postgraduate Medical Journal · doi:10.1136/pgmj.56.653.149 · Cited by 111
Jackman, D. M., Cioffredi, L. A., Jacobs, L., Sharmeen, F., Morse, L. K., Lucca, J. V., Plotkin, S. R., Marcoux, P. J., Rabin, M. S., Lynch, T. J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2886 · Cited by 105
Chamberlain, M. C., & Kormanik, P. A. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005803918194 · Cited by 100
Masuda, T., Hattori, N., Hamada, A., Iwamoto, H., Ohshimo, S., Kanehara, M., Ishikawa, N., Fujitaka, K., Haruta, Y., Murai, H., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1555-6 · Cited by 98
Yang, J. C., Kim, D., Kim, S., Cho, B. C., Lee, J.-S., Ye, X., Yin, X., Yang, Z., Jiang, H., & Ahn, M. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.9002 · Cited by 95
Chamberlain, M. C. (2002) · Cancer · doi:10.1002/cncr.10547 · Cited by 93
Siegal, T. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005999228846 · Cited by 86
New Strategies in the Management of Leptomeningeal Metastases
Groves, M. D. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.18 · Cited by 85
Kawamura, T., Hata, A., Takeshita, J., Fujita, S., Hayashi, M., Tomii, K., & Katakami, N. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2759-y · Cited by 79
Gani, C., Müller, A., Eckert, F., Schroeder, C., Bender, B., Pantazis, G., BAMBERG, M., & Berger, B. (2012) · Strahlentherapie und Onkologie · doi:10.1007/s00066-011-0025-8 · Cited by 75
EGFR mutation status in brain metastases of non-small cell lung carcinoma
Burel‐Vandenbos, F., Ambrosetti, D., Coutts, M., & Pédeutour, F. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0990-5 · Cited by 74
Bot, I., Blank, C. U., & Brandsma, D. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6488-4 · Cited by 72
Daniele, L., Cassoni, P., Bacillo, E., Cappia, S., Righi, L., Volante, M., Tondat, F., Inghirami, G., Sapino, A., Scagliotti, G. V., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a52359 · Cited by 72
Lin, N., Dunn, I. F., Glantz, M., Allison, D. L., Jensen, R. L., Johnson, M. D., Friedlander, R. M., & Kesari, S. (2011) · Journal of neurosurgery · doi:10.3171/2011.5.jns101768 · Cited by 70
Momtaz, P., Pentsova, E. I., Abdel-Wahab, O. I., Diamond, E. L., Hyman, D. M., Merghoub, T., You, D., Gasmi, B., Viale, A. J., & Chapman, P. B. (2016) · Oncotarget · doi:10.18632/oncotarget.13397 · Cited by 69
Shapiro, W. R., Schmid, M., Glantz, M., & Miller, J. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.1528 · Cited by 68
Carcinomatous Meningitis in Non–Small-Cell Lung Cancer: Response to High-Dose Erlotinib
Dhruva, N., & Socinski, M. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.0963 · Cited by 64
Vemurafenib for Leptomeningeal Melanomatosis
Schäfer, N., Scheffler, B., Stuplich, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.5773 · Cited by 59
Ou, S. I., Sommers, K. R., Azada, M. C., & Garon, E. B. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0309 · Cited by 57
Chamberlain, M. C. (2010) · Seminars in Neurology · doi:10.1055/s-0030-1255220 · Cited by 57
Sasaki, S., Yoshioka, Y., Ko, R., Katsura, Y., Namba, Y., Shukuya, T., Kido, K., Iwakami, S., Tominaga, S., & Takahashi, K. (2015) · Respiratory Investigation · doi:10.1016/j.resinv.2015.07.001 · Cited by 54
New aspects of immunotherapy of leptomeningeal metastasis
Herrlinger, U., Weller, M., & Schabet, M. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005948722912 · Cited by 46
Kuiper, J. L., & Smit, E. F. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2012.12.024 · Cited by 46
Central Nervous System Cancers
Brem, S. S., Bierman, P. J., Black, P. M., Brem, H., Chamberlain, M. C., Chiocca, E. A., DeAngelis, L. M., Fenstermaker, R. A., Friedman, A., Gilbert, M. R., et al. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0037 · Cited by 46
Lu, N. T., Raizer, J. J., Gabor, E. P., Liu, N. M., Vu, J. Q., Slamon, D. J., & Barstis, J. L. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-015-0084-y · Cited by 33
Souchon, R., Feyer, P., Thomssen, C., Fehm, T. N., Diel, I., Nitz, U. A., Janni, W. J., Bischoff, J., & Sauer, R. (2010) · Breast Care · doi:10.1159/000322661 · Cited by 33
CNS Infections in Patients With Cancer
Pruitt, A. A. (2012) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000413665.80915.c4 · Cited by 33
Chahal, J., Stopeck, A., Clarke, K., Livingston, R. B., & Chalasani, P. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2259-1 · Cited by 31
Afatinib combined with cetuximab for lung adenocarcinoma with leptomeningeal carcinomatosis
Lin, C.-H., Lin, M., Kuo, Y.-W., & Ho, C. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.06.002 · Cited by 28
Simeone, E., Maio, E. D., Sandomenico, F., Fulciniti, F., Lastoria, S., Aprea, P., Staibano, S., Montesarchio, V., Palmieri, G., Mozzillo, N., et al. (2012) · Journal of Medical Case Reports · doi:10.1186/1752-1947-6-131 · Cited by 26
Xing, P., Li, J., Shi, Y., & Zhang, X. (2013) · Thoracic Cancer · doi:10.1111/1759-7714.12049 · Cited by 7
Tamiya, M., Shiroyama, T., Nishihara, T., Nishida, T., Hayama, M., Tanaka, A., Morishita, N., Suzuki, H., Okamoto, N., & Hirashima, T. (2016) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12643 · Cited by 6
p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
Epidemiology of brain metastases and leptomeningeal disease
Lamba, N., Wen, P. Y., & Aizer, A. A. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab101 · Cited by 406
Metadata
- Authors
- Wang, N., Bertalan, M. S., & Brastianos, P. K.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2017-11-22
- Volume
- 124
- Issue
- 1
- Pages
- 21-35
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2768584883
- Cited by
- 262
- References
- 89
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.